The ASCI was established in 2004 and brings together world-class physician-scientists from diverse areas of biomedical research to explore the intricacies of stem cells—the primitive, unspecialized cells with an unrivaled capacity to form a variety of cells, tissues and organs in the body. The Institute attracts many of the best and brightest young researchers in the field, who are committed to taking a bold path to redefine the possibilities of medicine and speed breakthrough discoveries from the lab bench to the patient bedside.
The Cardiovascular Research Institute is dedicated to understanding the molecular, cellular, and genetic underpinnings of cardiovascular disease, with the goal of improving heart health for patients worldwide.
The Caryl and Israel Englander Institute for Precision Medicine is a translational research hub, which opened under the direction of renowned pathologist and prostate cancer expert Dr. Mark Rubin. The IPM team includes clinicians, basic scientists, pathologists, molecular biologists, and computational biologists. These physician-scientists are directing their collective expertise and wealth of knowledge to pinpoint the molecular underpinnings of disease and spur the discovery of novel therapies.
The Center for Research on End of Life Care was established in 2014 to improve the quality of life and care provided to patients and families confronting life-threatening illness and death.
The Center’s mission is to improve our understanding of the biologic properties of the Hepatitis C virus and identify new treatments for this disease.
The Center connects vascular biologists from Weill Cornell and neighboring institutions. Weill Cornell vascular biologists use modern tools of biomedical research to investigate the structure and function of vessel wall cells.
The CTSC aims to provide an environment that allows optimal use of our multi-institutional assets and our diverse patient population to move translational research from bench to bedside and to the community.
The core mission of the Brain and Mind Research Institute (BMRI) is to advance the recognition and treatment of brain disorders by elucidating their fundamental mechanisms and translating these advances into novel preventive and therapeutic strategies for patients. The BMRI is committed to training and mentoring the next generation of scientists and physician-scientists working in the neurosciences.
The mission of the Gale and Ira Drukier Institute for Children’s Health is to accelerate translational research in order to better understand diseases that start in childhood. Members of the Institute conduct novel basic and translational research and participate in training and educational programs across the Department of Pediatrics at Weill Cornell Medicine.
The Helen and Robert Appel Alzheimer’s Disease Research Institute mission is to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected.
The ICB at Weill Cornell integrates genomic and cellular data with the larger issues of biomedicine, focusing on computational systems biology and biomedical informatics.
The Institute’s vision is to advance research and education in the study of public health response logistics. The research includes developing models to prepare for natural or man-made disasters and disease epidemics.
The Weill Cornell Institute of Geriatric Psychiatry conducts research in geriatric psychiatric disorders, trains investigators and clinicians and provides specialized care to older adults.
The mission of the Jill Roberts Institute is to establish a multidisciplinary center of excellence that will accelerate new cutting-edge scientific discoveries at both the basic and translational level, which collectively will advance innovative preventative and therapeutic approaches for Inflammatory Bowel Disease (IBD) and other related inflammatory diseases.
The Institute is internationally known for developmental research and training, identifying first steps toward individualized and targeted treatments for psychiatric disorders.
The Sandra and Edward Meyer Cancer Center aims to bring innovations from the bench to the bedside and back again, through collaborations with researchers who focus on therapies that will benefit our patients.
The Tri-Institutional Therapeutics Discovery Institute links researchers with experts in drug discovery from the biotech and pharmaceutical industries.